HLA-DR15

HLA-DR15 is a human leukocyte antigen serotype within the HLA-DR serogroup. The serotype is determined by the antibody recognition of HLA-DRB1*15 and *16 gene products. This broad antigen group is produced by two similar genes, HLA-DRB1 and HLA-DRB5, which are inherited together. HLA-DR15 and HLA-DR51 are commonly inherited together and are linked with several autoimmune conditions and diseases.

Structure and Function

HLA-DR15 is a part of the Major Histocompatibility Complex (MHC) class II molecules, which are expressed in antigen-presenting cells (APCs). The primary function of these molecules is to present processed antigenic peptides to T cells. HLA-DR15, like other MHC class II molecules, is a heterodimer consisting of an alpha (DRA) and beta chain (DRB), the latter being encoded by HLA-DRB1 or HLA-DRB5 genes.

Association with Diseases

HLA-DR15 has been associated with a number of autoimmune diseases. These include multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. It is also associated with a higher risk of narcolepsy, Hodgkin's lymphoma, and pemphigus vulgaris.

Clinical Significance

The presence of HLA-DR15 can be determined through HLA typing, which can be useful in predicting susceptibility to certain diseases. However, it is not used as a diagnostic tool due to the complex nature of these diseases.

See Also

• HLA-DR
• Human leukocyte antigen
• Major Histocompatibility Complex
• Autoimmune disease

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian